These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 16526139)
1. Rights, patents, markets and the global AIDS pandemic. Gathii JT Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139 [No Abstract] [Full Text] [Related]
2. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]
3. International intellectual property, access to health care, and human rights: South Africa v. United States. Nagan WP Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137 [No Abstract] [Full Text] [Related]
4. Access to treatment for HIV/AIDS: a human rights issue in the developing world. Joni J Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296 [No Abstract] [Full Text] [Related]
5. Access to essential drugs, human rights and global justice. Shalev C Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024 [No Abstract] [Full Text] [Related]
6. Essential AIDS medications in India. Thomas J Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350 [No Abstract] [Full Text] [Related]
7. AIDS and drug pricing: in search of a policy. Salbu SR Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750 [No Abstract] [Full Text] [Related]
8. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries. Spectar JM Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914 [No Abstract] [Full Text] [Related]
9. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
10. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective. Viana JM Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298 [No Abstract] [Full Text] [Related]
11. Not just a tragedy: access to medications as a right under international law. Yamin AE Boston Univ Int Law J; 2003; 21(2):325-71. PubMed ID: 16514750 [No Abstract] [Full Text] [Related]
12. Access to essential medicines: a Hobbesian social contract approach. Ashcroft RE Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722 [TBL] [Abstract][Full Text] [Related]
13. Ethics and AIDS drugs. Dowell W Time; 1999 Jul; 154(2):49. PubMed ID: 10538646 [No Abstract] [Full Text] [Related]
15. Access to HIV drugs: are we changing the two world paradigm? Lazzarini Z Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297 [No Abstract] [Full Text] [Related]
16. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
17. Patients v. patents?: policy implications of recent patent legislation. Katopis CJ St Johns Law Rev; 1997; 71():329-401. PubMed ID: 11658166 [No Abstract] [Full Text] [Related]
18. No money, no meds. Mabry M Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648 [No Abstract] [Full Text] [Related]
19. Access to affordable HIV/AIDS drugs: the human rights obligations of multinational pharmaceutical corporations. Ferreira L Fordham Law Rev; 2002 Dec; 71(3):1133-79. PubMed ID: 12523370 [No Abstract] [Full Text] [Related]
20. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS. Curti AM Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145 [No Abstract] [Full Text] [Related] [Next] [New Search]